TABLE 2

Detailed PET/CT Results

	PET/CT				Prostatic fossa			Pelvic			Extrapelvic
Patient no.	Probe	Date	Positive result	PSA at PET/CT (ng/mL)	T	Detailed findings	SUV_max	N	Detailed findings	SUV_max	M	Detailed findings	SUV_max
1	¹⁸F-fluciclovine	4/12/2017	0	10.6	0			0			0
	⁶⁸Ga-PSMA-11	5/19/2017	1	10.9	0			1	1 external iliac LN (5 mm)	7.7	1	3 retroperitoneal LNs (4–5 mm)	17.1
												1 thoracic LN	4.4
												1 bone met (T8)	5.1
2	¹⁸F-fluciclovine	3/16/2017	0	12.27	0			0			0
	⁶⁸Ga-PSMA-11	6/7/2017	1	12.66	0			1	Multiple common iliac and presacral LNs (6–8 mm)	2	1	Multiple lung nodules (6–10 mm)	2.6
												1 bone met (T11)	6
3	¹⁸F-fluciclovine	3/15/2017	1	18.10	1	Faint localized uptake in left lobe	3.5	0			0
	⁶⁸Ga-PSMA-11	7/10/2017	1	31.30	1	Intense diffuse bilateral uptake	8.9	0			1	Multiple retroperitoneal LNs (8–10 mm)	4.7
4	¹⁸F-fluciclovine	5/25/2017	0	1.50	0			0			0
	⁶⁸Ga-PSMA-11	7/24/2017	0	1.60	0			0			0
5	¹⁸F-fluciclovine	3/23/2017	0	0.22	0			0			0
	⁶⁸Ga-PSMA-11	7/31/2017	1	0.30	0			1	4 perirectal LNs (3–4 mm)	2.9	0
6	¹⁸F-fluciclovine	5/9/2017	0	0.13	0			0			0
	⁶⁸Ga-PSMA-11	9/15/2017	0	0.24	0			0			0
7	¹⁸F-fluciclovine	10/5/2017	1	0.50	0			1	1 external iliac LN (7 mm)	4.9	0
	⁶⁸Ga-PSMA-11	10/11/2017	1	0.65	0			1	1 external iliac LN (7 mm)	14.1	0
									1 obturator LN (4 mm)	3.0
8	¹⁸F-fluciclovine	9/19/2017	0	0.30	0			0			0
	⁶⁸Ga-PSMA-11	10/25/2017	0	0.33	0			0			0
9	¹⁸F-fluciclovine	8/8/2017	0	3.04	0			0			0
	⁶⁸Ga-PSMA-11	10/26/2017	1	3.90	0			1	Multiple common and external iliac LNs (4–8 mm)	12.6	1	Multiple retroperitoneal LNs (4–6 mm)	10.3
												Multiple thoracic LNs (4–8 mm)	16.1
10	¹⁸F-fluciclovine	10/11/2017	0	0.20	0			0			0
	⁶⁸Ga-PSMA-11	11/13/2017	1	0.30	0			1	1 common iliac LN (3 mm)	5.3	0

Met = metastasis.